References
- Anderson W. K., Quagliator D. A., Haugwitz R. D., Narayanan V. L., Wolpert-DeFllippes M. K. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) steroisomers of 1,2-diaminocyclohexane. Cancer Treatment Reports 1986; 70: 997–1002
- Burchenal J. H., Kalaher K., Dew K., Lokys L. Rationale for development of platinum analogs. Cancer Treatment Reports 1979; 63: 1493–1498
- Cohen J. D., Robins H. I. Hyperthermia enhancement of carboplatin in human leukemia cells in vitro. Cancer Research 1987; 47: 4335–4337
- Cohen J. D., Robins H. I., Schmitt C. L. Interactions of hyperthermia with carboplatin, cisplatin and ectoposide in human leukemia cells in vitro. Cancer Letters 1989; 44: 205–210
- Fisher G. A., Hahn G. M. Enhancement of cis-diaminedichloroplatin (cis-DDP) cytotoxicity by hyperthermia. Third international symposium: Cancer therapy by hyperthermia, drugs and radiation, Ft. Collins, Colorado, edited by L. A. Dethlefsen, and W. C. Dewey. National Cancer Institute Monograph 1982; 61: 255–257
- Rahman A., Roh J. K., Wolpert-DeFilippes M. K., Goldin A., Venditti J. M., Woolley P. V. Therapeutic and pharmacological studies tetrachloro(d,l-trans) 1,2-diaminocyclohexane platinum(IV) (tetraplatin), a new platinum analogue. Cancer Research 1988; 48: 1745–1752
- Smith J. H., Smith M. A., Litterst C. L., Copley M. P., Uozumi J., Boyd M. R. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat. Fundamental Applied Toxicology 1988; 10: 45–61
- Wilkoff L. J., Dulmadge E. A., Trader M. W., Harrison S. D., Jr., Griswold D. P., Jr. Evaluation of trans-tetrachloro-1,2-diamino-cyclohexane platinum(IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum(II). Cancer Chemotherapy and Pharmacology 1987; 20: 96–100